Results 271 to 280 of about 182,106 (353)

SGLT2 Inhibitors: The First Endothelial-Protector for Diabetic Nephropathy. [PDF]

open access: yesJ Clin Med
Viggiano D   +7 more
europepmc   +1 more source

METTL3/YTHDF3 m6A axis promotes ferroptosis in diabetic kidney disease by stabilizing TfR1

open access: yesJournal of Diabetes Investigation, EarlyView.
METTL3/YTHDF3 m6A axis promoted ferroptosis in DKD by stabilizing TfR1, which could provide a reference for DKD treatment. ABSTRACT Objective Diabetic kidney disease (DKD) is a common complication of diabetes. N6‐Methyladenosine (m6A) modification is a widely studied epigenetic mechanism.
Jinmei Zhang   +5 more
wiley   +1 more source

Administration of Trichinella spiralis Antigens Alleviated Diabetic Nephropathy in Diabetic Mice. [PDF]

open access: yesActa Parasitol
El-Kady AM   +8 more
europepmc   +1 more source

Classification of Japanese type 1 diabetes based on clinical phenotypes and its association with diabetic complications: Across‐sectional study

open access: yesJournal of Diabetes Investigation, EarlyView.
Distribution of cases by subgroup. Dots indicate each case. Lines connect each case to the centroid of each subgroup. BMI, body mass index; HbA1c, glycated hemoglobin. ABSTRACT Introduction Despite the increasing number of studies using machine learning to develop individualized treatment strategies, only a few have been conducted in patients with type
Takafumi Masuda   +6 more
wiley   +1 more source

Effect of SGLT‐2 inhibitors on COPD exacerbations in individuals with type 2 diabetes: A meta‐analysis and Bayesian sensitivity analysis

open access: yesJournal of Diabetes Investigation, EarlyView.
This systematic review and meta‐analysis evaluates the impact of SGLT‐2 inhibitors on COPD exacerbations in patients with Type 2 diabetes mellitus (T2DM). Our findings demonstrate that SGLT‐2 inhibitors significantly reduce the frequency of COPD exacerbations by 35% compared to other antidiabetic agents, offering dual benefits in glycemic control and ...
Muhammed Shabil   +14 more
wiley   +1 more source

A nomogram incorporating clinical and laboratory indicators for predicting metabolic dysfunction‐associated fatty liver disease in newly diagnosed type 2 diabetes patients

open access: yesJournal of Diabetes Investigation, EarlyView.
It is critical to develop a simple, cost‐effective and practical predictive measurement for screening MAFLD individuals in the early stage of T2DM. We developed a nomogram model based on eight clinical and laboratory indicators to predict MAFLD in patients with newly diagnosed T2DM.
Tingting Li   +4 more
wiley   +1 more source

Identification and verification of feature biomarkers associated with CD14+ monocytes in type 1 diabetes

open access: yesJournal of Diabetes Investigation, EarlyView.
ID1 was identified as the feature gene of CD14+ monocytes, which exhibited the well‐known ability of diagnosis and prediction of T1D. ABSTRACT Aims/Introduction Monocytes contribute to the immune dysregulation of pancreatic islets in Type 1 diabetes mellitus (T1D).
Jin Huang   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy